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Abstract
SYT (SYnovial sarcoma Translocated gene or SS18) is widely produced as two isoforms, SYT/L and SYT/S, that are thought to
function in the nucleus as transcriptional coactivators. Using isoform-specific antibodies, we detected a sizable pool of SYT
isoforms in the cytosol where the proteins were organized into filamentous arrays. Actin and actin-associated proteins co-
immunoprecipitated with SYT isoforms, which also co-sedimented and co-localized with the actin cytoskeleton in cultured
cells and tissues. The association of SYT with actin bundles was extensive yet stopped short of the distal ends at focal
adhesions. Disruption of the actin cytoskeleton also led to a breakdown of the filamentous organization of SYT isoforms in
the cytosol. RNAi ablation of SYT/L alone or both isoforms markedly impaired formation of stress fibers and focal adhesions
but did not affect formation of cortical actin bundles. Furthermore, ablation of SYT led to markedly impaired adhesion and
spreading on fibronectin and laminin-111 but not on collagen types I or IV. These findings indicate that cytoplasmic SYT
isoforms interact with actin filaments and function in the ability cells to bind and react to specific extracellular matrices.
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Introduction
SYT (SYnovial sarcoma Translocated gene or SS18) was
discovered as part of a nuclear chimeric protein coded by a
t(X;18)(p11.2;q11.2) translocation found in many synovial sarco-
mas [1]. This translocation fuses the SYT gene on chromosome 18
with either the SSX1, SSX2,o rSSX4 genes on the X chromosome.
Findings from several studies have indicated that the SYT/SSX
fusion proteins localize to the nucleus and function as potential
transcriptional co-activators and effectors of cell proliferation [2–
10]. Consequently, native SYT, though devoid of a consensus
nuclear localization signal, has also been considered to be a
nuclear proto-oncogene. Indeed, SYT protein can interact with
several transcription factors, such as acute leukemia-associated
transcription factor AF10, SWI/SNF proteins, the histone acetyl-
transferase p300, and others [2,11–17].
SYT is highly conserved among species [18,19]. Alternative
splicing produces at least four isoforms of SYT, and the most
prominent of these are the long (SYT/L; 56 kD) and short (SYT/
S; 50.5 kD) isoforms, which differ by inclusion of exon 8 in SYT/L
[19]. Although SYT contains potential SH2 and SH3 motifs and
an annexin-like QPGY-rich domain, it has no significant
homology to other proteins, other than Crest (SS18-like 1), a
nuclear protein implicated in neuronal development [20]. SYT is
widely expressed during development and in adult tissues [1,18].
Syt-null mice do not develop beyond E9.5 and have profound
defects in vascularization, cell migration, neural tube closure, and
fusion within the embryonic-maternal membranes [21,22].
Our interests in SYT sprang from our studies on cell-matrix
interactions in tissue repair [23–25]. Eid et al. [15] reported data
suggesting thatactivationofb1 integrinsis associated with formation
of SYT/p300 complexes. Our findings also demonstrate a role for
SYT isoforms in cell-matrix interactions but indicate that cytosolic
SYT - the biology of which has not been explored - is the critical
pool that functions in adhesion. We found that cytosolic SYT
isoforms bind F-actin and are involved in cytoskeletal organization.
Ablation of SYT led to impaired assembly of actin stress fibers and
cell spreading and adhesion on specific extracellular matrix
substrata (fibronectin and laminin-111) but not others (types I and
IV collagen). These findings indicatethat cytosolic SYT functions in
the differential signaling controlling how a cell responds and
distinguishes among specific extracellular cues.
Results
SYT Antibodies
We generated two polyclonal antibodies: one against the N-
terminal half of SYT, which is common to all isoforms, and the other
against the peptide sequence coded by exon 8, which is present only in
SYT/L. Both antibodies were affinity purified using the recombinant
or peptide antigens, and we confirmed the specificity of these
antibodies by several approaches. Immunoblotting and immunopre-
cipitation of human osteosarcoma U2OS cell lysates demonstrated
that the panSYT (pSYT) antibody reacted with both SYT/S
(50.5 kD) and SYT/L (56 kD) and that the SYT/L-specific antibody
detected only SYT/L (Figure 1A, B). Immunofluorescence revealed
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antigen (Figure 1C). Immunoprecipitation with SYT/L-specific
antibody cleared lysates of the larger isoform yet retained signal for
SYT/S, which was brought down by subsequent immunoprecipita-
tion with pSYT (Figure 1D). After immunodepletion with both
antibodies, lysates were cleared of all SYT immunoreactivity.
Targeted RNAi knock-down of the SYT/L isoform (Figure S1)
markedly reduced signal for SYT/L detected by either antibody
without affecting the levels of SYT/S protein and mRNA (Figure
1E). RNAi knock-down of SYT/S and SYT/L mRNAs markedly
reduced the immunofluorescence signal for SYT isoforms detected
with the pSYT antibody (Figure S1). Similar results with these assays
were obtained with all other cell types examined, including rat lung
fibroblasts (RLF), monkey kidney fibroblasts (Cos-1), and mouse
fibroblasts (3T3). These data demonstrate that our antibodies
specifically recognize SYT isoforms across mammalian species. In
addition, even though the epitope of the pSYT antibody is common
to all putative isoforms, we did not detect the other, less-abundant
SYT isoforms. Indeed, amplification of SYT cDNA confirmed that
SYT/S and SYT/L accounted for essentially all mRNAs detected,
with only a minor level (,1%) of transcript for the SYT/vs1 isoform
(not shown), which lacks exons 7 and 8.
SYT Isoforms Localize to the Cytoplasm
Immunofluorescence with either SYT antibody verified nuclear
signal in both cells and tissue (Figure 2A,B); however, signal for
SYT protein was also seen in the cytosol of all cells examined,
typically in a filamentous pattern (Figure 2A). In addition to
U2OS, RLF, and 3T3 cells, we detected filamentous cytosolic
SYT in human primary keratinocytes, human HaCaT keratino-
cytes, human diploid fibroblasts (HDF), human primary fibroblasts
(IMR90), human cervical carcinoma cells (HeLa), and monkey
kidney fibroblasts (CV-1 and Cos-1) (not shown). Furthermore,
prominent signal for cytosolic SYT was detected in all adult mouse
tissues examined, including all cell layers of the retina (Figure 2B),
intestine, lung, skin, cardiac muscle, spleen, brain, uterus, and
testis, among others (not shown). Thus, the cytoplasmic distribu-
tion of SYT was seen across tissues, cell types, and species.
Based on cell fractionation, about 20% of total SYT was
recovered in the cytosolic fraction (S1 in Figure 2C), which was
consistently seen among cell types. Immunoblotting for the nuclear
envelope proteins, lamin-A/C, demonstrated no detectable
contamination of nuclear contents in the cytosolic fraction. The
relatively strong signal for the b1 integrin subunit, used as a plasma
membrane maker, in the P1 pellet likely indicates that most of the
plasma membrane sedimented in nuclear pellet. Indeed, fraction-
ation of biotinylated surface proteins demonstrated that plasma
membrane are brought down in nuclear pellet (data not shown).
Further fractionation of the cytosolic sample (S1) by ultracen-
trifugation resulted in essentially all cytosolic SYT in the pellet
(P2), which was enriched with cytoskeletal and the remaining
membrane components (b1 integrin subunit). No signal for SYT
Figure 1. SYT antibodies. (A) Total lysate (40 mg protein) from U2OS cells was immunoblotted (IB) with affinity-purified panSYT antibody (pSYT) or
antibody specific for the SYT/L isoform. The pSYT antibody reacted with both SYT/S (S; 50.5 kD) and SYT/L (L; 56 kD) isoforms, whereas the SYT/L
antibody reacted only with the long isoform. (B) Total cell lysates were immunoprecipitated with pSYT or SYT/L-specific antibodies or purified IgG. (C)
Cos-1 cells were processed for immunofluorescence staining with SYT/L antibody in the presence of increasing molar ratios (relative to antibody) of
antigenic peptide. Bar=20 mm. (D) Total U2OS lysate was immunoprecipitated with SYT/L-specific antibody (1u IP), and the supernatant was re-
immunoprecipitated with pSYT (2u IP). Both immunoprecipitates, as well as the starting lysate (Pre IP) and the supernatant after the second
immunoprecipitation (Post IP), were immunoblotted with pSYT antibody. (E) Lysates from control U2OS cells or from cells 3 days post transfection
with RNAi duplex 894, which targets only SYT/L transcripts (see Figure S1), were immunoblotted with pSYT and SYT/L-specific antibodies.
doi:10.1371/journal.pone.0006455.g001
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which contained soluble proteins (e.g., RhoGDI) and vesicles
(EEA1). Because we did not detect SYT protein on plasma
membrane by immunofluorescence (Figure 2A), we hypothesized
that cytosolic SYT isoforms were associated with cytoskeletal
components in the P2 pellet. Consistent with this idea, exposure to
cytochalasin D, which depolymerizes filamentous actin, abolished
the cosedimentation of SYT isoforms with the cytoskeleton (Figure
3A,B). SYT isoforms sedimented with filamentous (F) actin pools;
however, in the presence of cytochalasin D, the level of SYT in the
F-actin fraction was markedly reduced. These findings indicate
that cytosolic SYT isoforms localized in a subcellular compartment
associated with actin cytoskeleton and not with a membrane
compartment.
Cytosolic SYT is an Actin-associated Protein
We immunoprecipitated SYT from cytosolic lysates and
identified co-precipitated proteins by tandem mass spectrometry
(MS/MS). Immunoprecipitation of U2OS or Cos-1 lysates with
pSYT or SYT/L-specific antibodies consistently brought down
two prominent specific bands (Figure 3C,D). The larger of these
resolved as a doublet (Band 1) and contained myosin II heavy
chains (MHC) 9 and 10 and the faster migrating band (Band 2)
was identified as actin. MS/MS sequencing of the excised bands
revealed several peptides (9 to 19) for these proteins (Figure S2),
providing strong evidence for their identity. Importantly, no other
peptides were detected in the excised bands. To assess the
specificity of these interactions, we compared immunoprecipitates
of control cells and cells with RNAi-ablation of SYT isoforms
(verification and controls for the RNAi’s are discussed below). The
total level of actin was not affected by SYT ablation, but actin and
MHCs were not brought down with SYT antibodies from lysates
of RNAi knock-down cells (Figure 3C). In some co-immunopre-
cipitates, we identified hnRNP U (Band *), a ribonucleoprotein
that interacts with actin [26]. MHC 9 and 10 and actin also co-
immunoprecipitated with SYT from lysates of 3T3, Cos-1, RLF,
and HeLa cells (data not shown).
Rho GTPase controls the interaction between actin and myosin
II [27–29]. To assess if the interaction of SYT isoforms with actin
and MHCs was dependent on GTPase activity, we incubated
lysates with nonhydrolyzable GTP-cS or excess GDP to increase
or decrease GTPase activity, respectively, and then immunopre-
cipitated with pSYT antibody. Although many interactions may
be disturbed by GTP-cS or GDP, the recovery of co-immuno-
Figure 2. Cytosolic SYT. (A) Rat lung fibroblasts (RFL) and 3T3 fibroblasts were stained with pSYT antibody, and U2OS cells were stained with pSYT
or SYT/L-specific antibodies. Bar=10 mm. (B) Mouse retina was stained for SYT/L. Nuclear signal was seen in ganglion cells (GC) and cells of the inner
(INL) and outer (ONL) nuclear layers and within the choroid (C). Prominent cytoplasmic signal was seen within the inner (IPL) and outer (OPL)
plexiform layers, the photoreceptors (PR), and the choroid. (C) Total lysate (T) of U2OS cells was separated by centrifugation into cytoplasmic
supernatant (S1) and nuclear pellet (P1). The S1 cytosolic fraction was separated further by ultracentrifugation, yielding supernatant (S2) and pellet
(P2). Samples were resolved by electrophoresis and immunoblotted with antibodies against total SYT (pSYT), lamin-A/C, EEA-1, RhoGDI, and the b1
integrin subunit.
doi:10.1371/journal.pone.0006455.g002
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containing GTP-cS than from lysates with GDP (Figure 3D). In
contrast, the level of co-immunoprecipitated actin differed less
than 5% between conditions and among experiments (Figure 3D).
These co-immunoprecipitation results, along with the cosedimen-
tation with F-actin, were consistently seen among experiments and
indicate that SYT isoforms interact, directly or indirectly, with
actin and that actin-bound MHCs are brought down in a higher
order complex.
SYT Colocalizes with F-actin
Cytosolic SYT was organized into filamentous strands, which
were seen in all cell types examined (Figure 4A-C). Consistent with
the co-immunoprecipitation and co-sedimentation data (Figure 3),
we saw extensive colocalization of SYT with filamentous actin
(Figure 4), especially at branch points (Figure 5A). Colocalization
of SYT with F-actin was seen in every cell type examined and was
revealed with either pSYT or SYT/L-specific antibodies (Figure 4,
5A). The association of SYT strands with actin filaments
diminished gradually toward the distal ends of stress fibers at the
cell periphery, and as demonstrated by a lack of merged signal
with paxillin, SYT did not extend into focal adhesions (Figure 5B).
Colocalization of SYT with the actin cytoskeleton was also seen in
many tissues and was particularly evident at the apical-lateral
border edge of the intestinal epithelium (Figure 4D,E), uterus,
seminiferous tubules, kidney tubules, and more (not shown).
We assess if SYT was linked to actin polymerization. Both SYT
strands and F-actin collapsed upon exposure to cytochalasin D
(Figure 6) or latrunculin (data not shown). After a 1-h wash to
remove the depolymerization agents, SYT strand organization
recovered concomitantly with the reestablishment of an actin
cytoskeleton. Reformation of SYT strands and their colocalization
with actin filaments was not disrupted by actinomycin D, an RNA
polymerase inhibitor, or by leptomycin B, an antagonist of Crm1-
Figure 3. Cytosolic SYT isoforms interact with actin. (A) U2OS cells were treated with vehicle (Cnt) or 4 mM cytochalasin D (Cyt D)for 30 min
and then G and F actin pools were isolated and immunoblotted with pSYT antibody. Shown are independent triplicates. (B) Densitometric values of
the bands in the gels in panel A were averaged and normalized to the original lysate volume. The data shown are the mean6SEM of the normalized
densities from 3 independent experiments. (C) U2OS cells were transfected with panSYT229 RNAi duplex (see Figure S1) or control RNAi duplex, and 3
days later, post-nuclear lysates were immunoprecipitated with SYT/L or pSYT antibodies. Lysates were immunoblotted for actin, which demonstrated
equal loading among lanes and no decrease in total actin levels in RNAi-ablated cells. (D) Cos-1 lysates were pre-incubated with GTP-cS or GDP for
30 min at 30uC before immunoprecipitation with control IgG or pSYT antibody. Co-immunoprecipitated bands in both gels were visualized by SYPRO
Ruby staining, and the specific bands (1, 2, *) were excised, sequenced by MS/MS (see Figure S2), and identified as myosin heavy chains 9 and 10 (1),
actin (2), and hnRNP U (*). The nonspecific bands migrating between 50–80 kD are IgG subunits.
doi:10.1371/journal.pone.0006455.g003
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PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6455Figure 4. Cytosolic SYT colocalizes with actin filaments. U2OS (A,B) and RLF (C) cells and mouse colon (D,E) were stained with rhodamine-
conjugated phalloidin (actin) and pSYT or SYT/L-specific antibody. (A-C) Signal for SYT proteins colocalized extensively with the well formed arrays of
stress fibers in all cells. (D) SYT also colocalized with the actin network at the apical edge of colon epithelial cells. The boxed area in the merged
micrograph is expanded in panel D’. (E) A section of colon mucosa form another mouse showing nearly complete overlap with filamentous actin at
the apical-lateral borders of epithelia cells. Bars=10 mm for panels A-C and 25 mm for D and E.
doi:10.1371/journal.pone.0006455.g004
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lasin D (Figure 6). These data indicate that active transcription and
nuclear export are not required for formation of cytosolic SYT
strands or their association with the actin cytoskeleton. Further-
more, SYT strands did not colocalize with tubulin, and their
structure remained intact after disruption of microtubules (Figure
S3).
SYT Functions in Assembly of F-Actin
We used RNAi knock-down to assess if SYT isoforms function in
actin assembly and cell adhesion. We first determined the turnover
rate of SYT isoforms by pulse-chasing U2OS, Cos-1, and HeLa
cells with [
35S]methionine/cysteine. The half-life of SYT/L was
14.5 h and 13.6 h for SYT/S, and these rates did not vary
appreciably among cell types (data not shown). We designed seven
RNAi duplexes targeting sequences common to both SYT/L and
SYT/S (panSYT) mRNAs and two RNAi duplexes specific for
SYT/L mRNA (Figure S1). Of the panSYT duplexes, RNAi 97,
229, 471, and 503 reproducibly reduced total SYT mRNA
levels.95% and total SYT protein to levels undetectable by
immunoblotting at 3 days post-transfection (.5 half-lives) of U2OS
and Cos-1 cells (Figure S1). A few cells transfected with panSYT229
had weak residual nuclear staining for SYT but no cytosolic signal.
The immunofluorescence data also demonstrated that the trans-
fection efficiency of the RNAi duplexes was essentially 100%. We
obtained partial (50–90%) knock-down of total SYT with RNAi
duplexes 180, 414, and 838. Specific ablation of SYT/L mRNA
and protein was achieved with the SYT/L-specific RNAi duplexes
894 and 933, which did not affect expression of the SYT/S isoform
(Figure 1E; Figure S1). As shown below, we obtained the same
phenotype with all effective RNAi duplexes.
We transfected U2OS cells with control (similar GC content),
panSYT97, panSYT229, panSYT471, or SYT/L-specific RNAi
duplex 894 and assessed the formation of stress fibers 3 days later
(Figure 7). Whereas well-formed cytoskeleton was seen in cells
transfected with control or SYT/L-specific RNAi’s, stress fibers
Figure 5. SYT accumulates at junctions of actin filaments. (A) U2OS cells were stained with rhodamine-conjugated phalloidin (red) and with
pSYT antibody (green) and viewed by confocal microscopy. The micrographs shown are a single 30-nm z-section through the center of a cell. The
boxed area in the merged micrograph (upper left panel) is shown under high magnification in the other three. Arrows point to bends and junctions
in actin filaments with strong co-localization of SYT. (B) U2OS cells were immunostained with pSYT (green) and paxillin (red) antibodies. Arrowheads
demarcate the junctions between paxillin-positive focal adhesions and SYT staining.
doi:10.1371/journal.pone.0006455.g005
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PLoS ONE | www.plosone.org 6 July 2009 | Volume 4 | Issue 7 | e6455Figure 6. Organization of cytosolic SYT is dependent on actin polymerization. U2OS cells were treated with DMSO (Control) or 4 mM
cytochalasin D (Cyto-D) for 90 min, washed for 1 h in complete medium (Wash), and stained with pSYT antibody (green) and rhodamine-conjugated
phalloidin (red). Other cultures were pretreated with 1.25 mg/ml actinomycin D or with 20 mg/ml leptomycin B for 5 h before addition of cytochalasin
D; the presence of these compounds was maintained during the cytochalasin D treatment and subsequent wash steps. Bar=15 mm.
doi:10.1371/journal.pone.0006455.g006
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7). Total actin levels were not affected in RNAi-ablated cells
(Figure 3A). Furthermore, in the absence of total SYT, cortical
actin was still detected and we noticed robust membrane ruffling
and exaggerated filopodia formation (Figure 7, inset), indicating
that SYT is not needed for actin polymerization within certain
Figure 7. Ablation of SYTs impairs formation of stress fibers and focal adhesions. (A) At 3 d post transfection with control, panSYT229,o r
SYT/L894-specific RNAi duplexes, U2OS cells were stained with phalloidin (actin; red) or co-stained with phalloidin and FAK, pan-phosphotyrosine, or
paxillin antibodies (green). The inset in the middle column highlights the exaggerated filopodia, presence of cortical F-actin, and absence of stress
fibers in cells transfected with panSYT229 RNAi duplexes. (B) Similar experiment with different (panSYT97 and panSYT471) panSYT RNAI duplexes.
Bars=20 mmo r5mm (inset in A).
doi:10.1371/journal.pone.0006455.g007
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fibers but retention of cortical actin bundles) was recently reported
for fibroblasts isolated from Syt-null mouse embryos [22]. In
addition, focal adhesions, identified by staining for FAK, paxillin,
and phosphotyrosine, were disrupted in panSYT RNAi-transfect-
ed cells (Figure 7A). We saw no overt change in stress fiber
formation or focal adhesion markers in cells with specific knock-
down of SYT/L, suggesting that SYT/S compensates for loss of
the larger isoform in adherent cells.
Cytoplasmic vs. Nuclear SYT
Findings from three studies indicated that stress fiber formation
required cytosolic SYT andwas notdependent onthenuclearstores.
First, as stated above, transfection with RNAi panSYT838 resulted in
partial knock down of total SYT levels, and as demonstrated by
immunofluorescence, the residual SYT was detected only in the
nucleus (Figure 8B). Despite the presenceofnuclearSYT,stress fiber
formation was disrupted in these cells as thoroughly as seen in cells
transfected with the more effective RNAi duplexes.
Second, we expressed full-length SYT/S with a triple repeat of
the SV40 large T antigen nuclear localization sequence (NLS) and
a GFP tag linked to the N-terminus. We transfected this chimera
(SYT/NLS/GFP) or control (NLS/GFP) plasmid into U2OS cells,
and 10 h later, transfected with panSYT229 or control RNAi
duplexes. In cells with control RNAi, we detected GFP signal only
in the nucleus of a subset of cells (Figure 8C1). In panSYT229-
transfected cells, we also detected GFP only in the nucleus,
indicating that the over-expressed recombinant transcript over-
whelmed RNAi knock-down, but we saw no evidence of stress
fiber recovery in these cells (Figure 8C2,3).
Third, in the presence of actinomycin D and leptomycin B,
colocalization of SYT with stress fibers was restored after removal
of cytochalasin D (Figure 6). These findings indicate that nuclear
events like transcription and export of nuclear proteins do not
affect the colocalization of SYT with stress fibers. A common
conclusion from these three studies was that cytosolic SYT
isoforms regulate actin organization independently of the nuclear
pools of this protein.
Figure 8. Nuclear SYT is not required for stress fiber formation. U2OS cells were transfected with control (A) or panSYT838 (B) RNAi duplexes
and stained 72 h later with phalloidin (red) and pSYT antibody (green). Despite persistent levels of nuclear SYT in panSYT838 knock-down cells, stress
fiber formation was not recovered. (C) U2OS cells were transfected with pCMV/GFP/SYT/NLS and 10 h later with control (Cnt) or panSYT229 RNAi
duplexes and stained 72 h later with phalloidin (red) and DAPI (blue). Because the plasmid transfection is less efficient than that for RNAi duplexes,
GFP fluorescence was seen in only a subset of cells (arrows). Bars=20 mm.
doi:10.1371/journal.pone.0006455.g008
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Our findings that SYT was needed for stress fiber and focal
adhesion formation suggested a role in cell-matrix adhesion. At 1
and 2 days post-transfection with RNAi duplexes, the total
number of cells did not differ among cells transfected with control,
panSYT229, or SYT/L-specific RNAi duplexes. However, be-
tween 2 and 3-days post-transfection, the number of control cells
had nearly doubled, whereas we saw a smaller increase in the total
number of cells transfected with panSYT229 or SYT/L-specific
RNAi (data not shown). Because we detected no difference in the
apoptotic or proliferative indices of transfected cells (data not
shown), we conclude that the reduction in the number of cells on
the surface at day 3 was a consequence of impaired adhesion.
We then assessed if SYT was required for the ability of cells to
adhere and spread on specific extracellular matrix substrata.
Three days post-transfection, adherent U2OS cells were harvest-
ed, and an equal number of viable cells were replated on matrix-
coated wells. Cells with ablation of total SYT (panSYT229 or
panSYT471) or SYT/L only (SYT/L894) had impaired adhesion to
fibronectin and laminin-111, but we saw no decrease in adhesion
of cells plated on type I or type IV collagens (Figure 9). Cells with
ablation of total SYT (panSYT229, panSYT471) and SYT/L only
(SYT/L894) remained rounded and did not spread on fibronectin
or on laminin-111 but did on the collagen matrices (Figure 10;
Figure S4, S5). Co-staining with phalloidin and paxillin antibody
demonstrated that stress fibers and focal adhesions were markedly
underdeveloped in all knocked-down cells on fibronectin or
laminin-111 but were well formed in cells plated on type I or IV
collagen (Figure 10; Figures S4, S5). These results indicate that
SYT/S was not able to compensate for the lack of SYT/L within
90 min after replating. At 5 h post-plating, cells with selective
ablation of the SYT/L isoform did spread similar to control cells
but with only occasional evidence of focal adhesion formation
(Figure 10). In knock-down cells on collagen, immunostaining for
phosphotyrosine was localized to adhesion complexes but was
diffuse in cells on fibronectin (Figure S5). These findings
demonstrate that SYT functions in the cytoskeletal machinery
used to differentiate among extracellular signals.
In knock-down cells on collagen, immunostaining for phospho-
tyrosine was localized adhesion complexes but was diffuse in cells
on fibronectin (Figure S5), suggesting a disturbance in downstream
pathways of fibronectin-mediated cell-matrix adhesion. Ablation
of cytosolic SYTs in U2OS cells cotransfected with panSYT229
RNAi duplex and GFP/SYT/NLS plasmid or transfected with
panSYT838 showed reduced spreading in addition to a defect in
stress fiber formation (Figure 8B,C). These findings indicate that
cytosolic SYT functions in the cytoskeletal machinery used to
differentiate among extracellular signals for cell-matrix adhesions.
Discussion
We report that SYT isoforms are present in the cytosol and
interactwith F-actin, particularly with stressfibersina varietyofcells
and tissues. Our data indicate that cytosolic SYT functions to
modulate cytoskeletal organization and adhesion in response to
specificmatrixsubstrata.SYT wasprominentlyassociatedwith stress
fibersinall tested cells and especially inU2OScells thathavedistinct
arrays of stress fibers, inclusive of ventral, dorsal, and transverse
bundles of actin filaments [30]. The association of SYT diminished
near the cell periphery and stopped short of focal adhesions.
The interactions between SYT and actin stress fibers were
reciprocal though not completely equal. As demonstrated in our
studies with cytochalasin D and latrunculin, actin polymerization
was required for formation of SYT strands. However, although
knock-down of SYT blocked stress fiber formation, it did not
impact total actin polymerization as gauged by exaggerated
filopodia and cortical actin filaments, a phenotype also seen in Syt-
null fibroblasts [22]. Furthermore, we easily detected actin by
Sypro Ruby staining in immunoprecipitations with SYT antibod-
ies (Figure 3A, B), but we did not see the SYT proteins themselves.
Although the isoforms could have been masked by the IgG heavy
chains (a seemingly parsimonious explanation), the lack of visible
stained bands at 50 and 55 kD in our immunoprecipitates suggests
that the stoichiometry of the SYT:actin interaction favors actin.
In polarized cells in vivo, such as like intestinal epithelial cells,
SYT colocalized with circumferential actin belt prominently
running along apical-lateral edges (Figure 4D,E), and based on
RNAi-cell culture studies, SYT may have an important role in the
organization and function of these cytoskeletal elements. In
support of this idea, contraction of circumferential actin belt in
lining epithelial cells is critical for closure of the neural tube [31],
and Syt-null mouse embryos have a marked defect in neural tube
closure (Kimura, 2009). Thus, it is possible that this phenotype
arises due to lack of an association of SYT with filamentous actin.
Our data also demonstrate that cytosolic SYT functions in
controlling adhesion to specific extracellular matrix substrates.
Integrins - heterodimers of a and b subunits - are the key receptors
that cells use to sense and respond to the pericellular extracellular
matrix environment. The ability of integrins to bind matrix ligands
and to transduce information of what they have encountered is
controlled by upstream (inside-out) receptor activation, formation
and maturation of focal complexes and adhesions, and down-
stream (outside-in) signal transduction, and each of these processes
has been functionally linked to the actin cytoskeleton [29,32–34].
We speculate that SYT functions primarily upstream of integrin
Figure 9. Ablation of SYT inhibits adhesion on specific
extracellular matrices. At 3 d post transfection, U2OS cells were
harvested, and equal number (2, 3, or 3.15610
5 per experiment) of
viable cells were plated on 6-well plates precoated with fibronectin,
laminin-111, type I collagen, or type IV collagen. Adherent cells were
detached 90 min later and counted. For control cells, the absolute
percent adhesion (mean6SEM) across experiments was 68.1%63.5 on
fibronectin; 58.1%64.6 on laminin-111; 51.7%63.0 on type I collagen;
and 47.0%61.2 on type IV collagen. Each datum point was normalized
to the averaged percent of control cells (control RNAi). Then all data
points were adjusted to their matrix-specific controls set at 100%. Both
graphs show the mean6SEM of independent experiments (n=3), and
each datum point is the average of triplicate determinations per
condition per experiment. *p,0.05 relative to scrambled RNAi
transfected cells.
doi:10.1371/journal.pone.0006455.g009
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specific cell-matrix interactions. The observations that filopodia
and cortical actin networks formed in SYT-ablated cells indicate
that many of the mechanisms downstream of integrin ligation -
particularly events mediated by the small GTPases Rac and cdc42
[29] - are not dependent on SYT. Furthermore, because focal
adhesions and stress fibers formed in SYT-ablated cells on types I
and IV collagen but not on fibronectin and laminin-111 and
because the integrins that bind fibronectin and laminins are
distinct from those that recognize collagens I and IV [34], SYT
may function selectively with the fibronectin/laminin-binding
integrins. Consistent with these ideas and our findings, Eid et al.
[15] reported that over-expression of dominant-negative SYT led
to decreased activation of b1 integrins and adhesion to fibronectin.
The observations that SYT-ablated cells bound to and spread
on collagen and formed focal adhesions suggests that activation of
collagen-binding integrins is not dependent on SYT and/or that
downstream signaling differs between fibronectin- and laminin-
Figure 10. SYT is required for cell spreading on fibronectin and laminin-111 but not on collagen. U2OS cells were transfected with
control, panSYT229, panSYT471, or SYT/L894 RNAi duplexes. Three days later, the transfected cells were harvested and replated on chamber slides
precoated with (A) fibronectin, (B) laminin-111, (C) type I collagen, or (D) type IV collagen. After a 90-min or 5-h incubation, the slides were gently
washed with PBS and stained with rhodamine-conjugated phalloidin (red), DAPI (blue) and anti-paxillin antibody (green). In some SYT/L RNAi-
transfected cells, cell spreading and few focal adhesions (arrows) were seen at 5 h post-plating. Bar=20 mm. (E) Cell spreading was quantified by
measuring and averaging the total cell area at the given times on the various substrata. For each condition, cells within 10 randomly selected areas
(620) from each of 3 experiments (.300 cells per point) were measured. Data are the mean6SEM and are normalized to the value of the 90-min
controls for each matrix. The horizontal line in each graph represents the extent of cell spreading at 15 min post-plating on the various matrices.
doi:10.1371/journal.pone.0006455.g010
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integrins can either inhibit or promote the ability of a2b1 to bind
collagen and, hence, signal [35–37], an upstream role for the actin
cytoskeleton has not been assessed for activation of collagen-
binding integrins. Integrin downstream signaling involves many
proteins, such as FAK, paxillin, a-actinin, vinculin, and many
others, that affect actin organization, among other processes
[33,34]. Although a few studies have suggested that different
integrins mediate different effects on Rho GTPase activity [38,39],
it is not clear how signaling downstream of one matrix-integrin
contact differs from that mediated by another interaction or how
multiple simultaneous signals are integrated. Our future studies
are aimed at assessing how cytosolic SYT functions to control
adhesion to specific matrix proteins.
Materials and Methods
Cells and Tissue
Human diploid fibroblasts (HDF) and NIH-3T3, U2OS, Cos-1,
IRM-90, HeLa, and 293 cells were purchased from ATCC
(Manassas VA). Rat lung fibroblasts (RLF) were isolated as
described [40]. Cos-1 and 3T3 cells were grown with DMEM, and
U2OS cells, RLF, and HDF were grown in McCoy’s 5A (ATCC),
F12K (ATCC), and EMEM (Mediatech, Herndon VA) media,
respectively. All culture media were supplemented with 10% FBS.
In some studies, cells were treated with 3 mg/ml nocodazole
(Calbiochem, La Jolla CA), 4 mM cytochalasin D (Calbiochem),
2 mM latrunculin (Calbiochem), 20 mg/ml leptomycin B (EMD,
San Diego, CA), or 1.25 mg/ml actinomycin D (EMD). Tissues
were harvested from 6-week old C57BL/6 mice and processed for
immunostaining as described [41].
SYT Protein and Antibodies
Full length cDNAs of human SYT/L and SYT/S were cloned
by reverse transcription-PCR (RT-PCR) of total RNA from 293
cells using primers shown in Figure S6. RNA was isolated with
Trizol (Invitrogen, Carlsbad, CA) and transcribed into cDNA
synthesis Superscript II (Invitrogen). SYT cDNAs were amplified
with AccuPrime
TM taq (Invitrogen) with 28–30 cycles using
primers shown in Figure S6. PCR products were resolved through
1.2% agarose, and bands corresponding to SYT/S and SYT/L
were eluted and sequenced.
To generate antibodies reactive to both isoforms (panSYT), the
59 half of SYT cDNA, upstream of the alternatively spliced exon 8,
was amplified with the primers (Figure S6) and subcloned into
pGEX-KG and transformed into BL-21 competent cells (Strata-
gene, La Jolla CA). After a 2-h induction with IPTG, GST-tagged
fusion proteins were isolated from bacterial lysate by glutathione
agarose (Sigma, St. Louis MO) affinity chromatography. The GST
tag was removed using a Thrombin Cleavage Capture kit
(Novagen, Madison WI) and glutathione agarose batch chroma-
tography and removal was confirmed by immunoblotting with
anti-GST (Upstate, Lake Placid NY). To generate an SYT/L-
specific antibody, a 15-amino acid peptide (YPEQGYDR-
PYEDSSQ), representing the sequence coded by exon 8, was
selected using the Peptideselect
TM design tool (peptideselect.invi-
trogen.com/peptide/). Purified recombinant SYT (8 mg) and
SYT/L peptide (20 mg) were sent to Evoquest
TM (Invitrogen) to
raise polyclonal antibodies in rabbits and for affinity purification.
Immunoprecipitation
Cells were grown to about 80% confluency, washed, and
dounced homogenized and centrifuged or lysed in MLB buffer
(Upstate; 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% Igepal CA-
630, 10 mM MgCl2, 1 mM EDTA, 2% glycerol, 1 mM ATP). To
affect GTPase activity, lysates were adjusted to 10 mM EDTA and
100 mM GTPcS or 1 mM GDP and incubated for 30 min at
30uC. The reactions were stopped by chilling on ice and adding
60 mM MgCl2. Primary antibodies (1 mg) were incubated
overnight with 600 mg (total protein) of post-nuclear or whole cell
lysates in 600 ml. Protein quantitation was done with a BCA assay
kit (Pierce, Rockford IL). For co-immunoprecipitation studies,
antibody-bound complexes were brought down with Protein G
PLUS-Agarose (Santa Cruz, Santa Cruz CA). Immunoprecipitat-
ed products were washed 3 times with 1 ml RIPA buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% deoxycholate 1% NP-
40, 1 mM EDTA) and dissolved in SDS loading buffer at 95uC for
10 min and resolved through SDS-PAGE gels (8, 10, or 12%
acrylamide). Co-immunoprecipitated bands were identified by
staining with Sypro Ruby (BioRad, Hercules CA), excised and sent
to Midwest Bio Services (Overland Park KS) for sequencing by
nano LC/MS/MS.
Immunoblotting
After electrophoresis, gels were equilibrated in TGMS buffer
(1X Tris Glycine buffer, 20% methanol, 0.2% SDS), and proteins
transferred to PVDF membranes. True blot
TM (e-Biosciences, San
Diego CA) was used to obscure detection of antibody chains. Gels
and filters were processed as described [25]. Band densities were
measured with NIH Image J software (rsb.info.nih.gov/ij).
Immunofluorescence/Confocal
Cells were plated on CC2-treated Lab-Tek
TMII 4-well chamber
slides (Nalge Nunc, Rochester NY), washed with PBS, fixed for
10 min in buffered formalin, and permeabilized in 2% BSA, 0.2%
Triton-X 100, PBS. Fixed cells were incubated for 30 min with
Image-iT
TMFX Signal Enhancer (Invitrogen) to minimize back-
ground fluorescence and then overnight with primary antibodies
at 4uC in a humidified chamber. PanSYT and SYT/L affinity-
purified antibodies were used at a final concentration of 0.83 ng/
ml. For controls, we used non-immunized purified rabbit IgG or
competition with excess antigenic peptide. Antibodies against
FAK, paxillin, actin, and tubulin were from BD Pharmagen (San
Diego CA) and pan-phosphotyrosine antibody 4G10 was from
Upstate (Charlottesville, VA). Bound primary antibodies were
detected with Alexa Fluor 488 anti-rabbit or Alexa Fluor 568 anti-
mouse antibodies (Molecular Probes, Eugene OR) diluted 1:1000.
Filamentous actin (F-actin) was detected with rhodamine-conju-
gated phalloidin (Molecular Probes) diluted 1:100 in Alexa Fluor
568 anti-mouse antibody solution (Molecular Probes). Epifluores-
cence images were captured using an Olympus BX-51 fluores-
cence/DIC microscope with U plan Apo 406/0.85 and 206/0.70
objectives and an Olympus DP25 5.5 megapixel digital camera.
Confocal images (0.2–0.3 mm intervals in the Z-plane) were
captured using a Zeiss LSM 510 META confocal microscope with
F Fluar 406/1.3 oil and Plan-Apo chromat 636/1.3 oil
objectives.
Subcellular and Actin Fractionation
Cells were grown to visual confluence and harvested and
scraped in 10 mM HEPES (pH 7.4), 1 mM EDTA, 0.25 M
sucrose with protease inhibitor cocktail (Roche, Nutley NJ) and
PhosStop phosphatase inhibitor cocktail (Roche). Cells were
dounce-homogenized thirty times, and homogenates were spun
at 2,5006g for 15 min to separate the nuclear pellet (P1) and
cytosolic supernatant (S1). The S1 fraction was centrifuged in a
TLA-100.3 rotor at 44,000 rpm at 4uC for 2 h to separate into S2
and P2 fractions. Fractions were resolved by electrophoresis and
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A/C (1:200; Abcam), early endosome antigen-1 (EEA-1; 1:1000;
Pharmagen BD), and RhoGDI (1:1000, Santa Cruz). The F- and
G-actin pools were isolated using a Cytoskeleton Isolation Kit
(BK039, Cytoskeleton, Denver CO). In brief, cell lysates treated
with or without 4 mM of cytochalasin D were centrifuged at
50,0006g for 1 h to separate the G-actin (supernatant) and F-actin
pools (pellet). The pellet was treated with 10% trichloroacetic acid
and resuspended in 1/10 vol (v/v) relative to the G-actin
supernatant. Equal aliquots of each were processed for immuno-
blotting.
RNAi Ablation
Several RNAi duplexes, targeting both SYT mRNAs or only
SYT/L mRNA, using BLOCK-iT
TM RNAi designer software
(rnaidesigner.invitrogen.com). Sequences for RNAi duplexes are
shown in Figure S6; the numbers used to designate each RNAi
refers to the first base targeted (relative to the SYT/L mRNA).
Stealth
TM RNAi Negative Control (medium GC content; product
number 12935–300; Invitrogen) duplexes were used as controls.
U2OS or Cos-1 cells (1.2610
6) were plated on 6-well plates 1 d
before transfection with Lipofectamine
TM 2000 or Lipofectami-
ne
TM RNAiMAX (Invitrogen). Cells were then collected at 1–4
days or passed at 3 days post-transfection for adhesion assays. To
generate pCMV-GFP SYT-NLS, we inserted full-length SYT/S
cDNA the into the NotI site of pShooter
TM (Invitrogen). To assess
mRNA levels, cDNA was generated with a High-Capacity cDNA
Archive kit (Applied Biosystems, Foster City CA) and amplified
using primers that spanned exons 4–11, thereby amplifying both
SYT/S and SYT/L transcripts. Sample loading and PCR
efficiency were assessed by amplification of GAPDH cDNA.
Adhesion and Spreading
U2OS cells (1.8610
6 viable cells) were plated on 10-cm culture
dishes and, transfected with RNAi duplexes, and the numbers of
attached and floating cells were determined daily for 3 days.
Adherent cells were detached with 5 mM EDTA-PBS and
suspended in serum-free McCoy5A medium, and 2–3.15610
5
viable cells were plated on specific ECM ligand precoated 6-well
plates (BD Biosciences). After a 90-min incubation, wells were
washed gently with PBS to remove unattached cells, and adherent
cells were detached with EDTA-PBS. Cell counts were done with
a hemocytometer. For spreading assays, U2OS cells were
detached 3 days post-transfection with EDTA-PBS, and 3–
4610
5 viable cells were plated on glass slides precoated with
fibronectin or type I collagen (BD Falcon
TM 8-well Culture Slides)
or on chamber slides coated with 50 mg/ml ultra-pure laminin-
111 or 100 mg/ml type IV collagen (BD Biosciences), as done in
other studies [23,42]. At 90 min or 5 h post-plating, slides were
processed for immunostaining. Epifluorescent images were
captured, and cell spreading was quantified using NIH Image J
software as average area per cell.
Supporting Information
Figure S1 RNAi Duplexes. (A) Sequences and Target Regions
of SYT RNAi Duplexes. Shown are the RNAi duplexes used in
these studies. The numbers indicate the position of the first
nucleotide. (B-D). SYT mRNA and Protein Levels. U2OS cells
were transfected with different RNAi duplexes, and the levels of
SYT proteins were assessed 3 days later by immunoblotting and
immunofluorescence with pSYT antibody and mRNA by RT-
PCR. Bar=20 mm.
Found at: doi:10.1371/journal.pone.0006455.s001 (1.15 MB TIF)
Figure S2 Protein Sequencing. The identity the co-immunopre-
cipitated bands seen in Figure 3A,B was determined by tandem
mass spectrometry (MS/MS). Bands were excised from SYPRO
ruby-stained gels and sent to Midwest Bio services (http://www.
midwestbioservices.com/index.html). At Midwest Bio, samples
were trypsin digested, concentrated on a peptide trap column, and
washed and desalted. The peptides were separated via micro-
capillary reverse-phase chromatography and sprayed directly into
the mass spectrometer. Full MS and MS/MS spectra were
acquired by an LCQ Deca XP Plus ion trap mass spectrometer
(ThermoFinnigan). The sequences of the parent peptides were
inferred by matching the MS/MS spectra to protein sequence
databases using TURBOSEQUEST software. The peptides
identified in the three excised bands are shown above. The co-
immunoprecipitated bands were free of other products.
Found at: doi:10.1371/journal.pone.0006455.s002 (0.12 MB TIF)
Figure S3 SYT does not Associate with Microtubules. (A,B)
U2OS cells were exposed to 3 mg/ml nocodazole for 30 min.
Whereas the microtubules were effectively disassembled, the
filamentous strands of SYT remained intact. Bar=10 mm (all
panels). (C) NIH3T3 cells were immunostained with pSYT
antibody and anti-tubulin antibody. Immunofluorescence signal
for SYT did not colocalize with that for microtubules. This cell
shows an absence of signal for nuclear SYT (dashed circle outlines
the nucleus). We have found that in many cell types, the levels of
nuclear SYT drop markedly during cytokinesis and recover hours
later.
Found at: doi:10.1371/journal.pone.0006455.s003 (4.62 MB TIF)
Figure S4 SYT is Required for Cell Spreading on Fibronectin
and Laminin 111 but Not on Collagen. This experiment is a
repeat of that shown in Figure 10, except that the cells were
stained with rhodamine-conjugated phalloidin and DAPI and the
images were captured at a lower magnification. U2OS cells were
transfected with scrambled, panSYT229, panSYT471,or SYT/L
RNAi duplexes. Three days later, the transfected cells were
harvested and replated on chamber slides precoated with (A)
fibronectin, (B) laminin-111, (C) type I collagen, or (D) type IV
collagen. After a 90-min or 5-h incubation, the slides were
processed for fluorescence staining. Bar=40 mm. Whereas all cells
with knock-down of total SYT (panSYT229 and panSYT471)
show persistent impairment of cell spreading and formation of
stress fibers and focal adhesions on fibronectin or laminin-111, a
few cells with knock-down of SYT/L have begun to spread and
form stress fibers at 5 h post-plating. In cells transfected with
panSYT471 and SYT/L-specific RNAi duplexes spread and form
stress fibers on either collagen type, very similar to control cells
(scrambled RNAi). Cells transfected with RNAi panSYT229 do
spread and form stress fibers on the collagen matrices.
Found at: doi:10.1371/journal.pone.0006455.s004 (4.03 MB TIF)
Figure S5 Ablation of Total SYT Inhibits Cell Spreading and
Stress Fiber Formation. U2OS cells were transfected with control
or panSYT471 RNAi duplexes, transferred 2 days later to glass
slides precoated with fibronectin or type I collagen. The cells were
stained 24 h post-plating with rhodamine-conjugated phalloidin
and antibodies against paxillin or pan-phosphotyrosine (P-Y). On
fibronectin, adherent RNAi knock-down cells were unable to
spread or form focal adhesions. In contrast, knock-down of total
SYT with panSYT471 RNAi did not affect cell spreading or
adhesion on type I collagen. Bar=20 mm.
Found at: doi:10.1371/journal.pone.0006455.s005 (4.32 MB TIF)
Figure S6 PCR Primers. Full length SYT cDNAs were cloned
by RT-PCR of RNA from 293 cells using AccuPrime Taq
SYT Associates with Actin
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generate pCMV-GFP-SYT/S and pCMV-GFP-SYT/L. To
generate an antigen common to both isoform, we amplified the
5 ` half of SYT cDNA upstream of the alternatively spliced exon 8
from pCMV-GFP-SYT/L. The PCR product was subcloned into
the SmaI-HindIII site of pGEX-KG plasmid. For semi-quantita-
tive RT-PCR, cDNA was synthesized from 3 mg of total RNA with
a High-Capacity cDNA Archive kit (ABI). SYT cDNAs were
amplified using primers that spanned exons 4-11, thereby
amplifying both SYT/S and SYT/L transcripts.
Found at: doi:10.1371/journal.pone.0006455.s006 (0.40 MB TIF)
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